Delivery Order SPE2DB22D3301-SPE2DB25FY7CC
Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $8.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,717.32, is for the delivery of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product, with a performance period ending on January 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award, with a ceiling value of $1,332.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a completion date of December 10, 2024. The contract is a Firm Fixed Price arrangement and was not designated with any set-aside requirements, indicating open...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,124.77 firm fixed-price delivery order is for the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS. The contract has an ultimate completion date of March 9, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $12,208.89 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,658,119 units of the drug Cefepime-Dextrose 2 GM/50 MLS. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Cefepime-Dextrose 2 GM/50 MLS, a generic pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $15,454.39 and an ultimate completion date of July 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cefepime-Dextrose 2 GM/50 MLS. The contract has a firm fixed price of $2,665.02 and a completion date of July 3, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,171,074 units of the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS. The contract has a ceiling value of $3,653.65 and an ultimate completion date of April 5, 2024. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,665.02 firm-fixed-price contract is for the delivery of the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS, with a period of performance through May 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,821.52, is for the provision of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of May 17, 2023 and is a Firm Fixed Price type contract. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, and has a ceiling value of $2,665.02. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...